COVID-19: The Time for Pocrastination Over Patents is Over.

Unless timely action is taken, South Africa could be faced with a new form of “pharmaceutical apartheid,” like that experienced in the early days of the AIDS response, when access to medicines here was blocked by decisions made by rich countries and pharmaceutical companies in the Global North, writes Professor Brook Baker in a co-authored op-ed for Spotlight.